Viventia Bio Inc, based in Winnipeg, Canada, is a biotechnology company specializing in innovative cancer therapies. With a focus on developing cutting-edge technologies and products, Viventia Bio is dedicated to advancing the field of oncology.
Driven by a team of experienced professionals and supported by a scientific advisory board, Viventia Bio is committed to bringing novel treatments to market to improve patient outcomes. Through their pipeline of promising products like VB4 845 Vicinium and VB4 847 Proxinium, the company aims to make significant contributions to the fight against cancer.
Generated from their website